Phibro Animal Health
PAHC
229 hedge funds and large institutions have $723M invested in Phibro Animal Health in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 84 reducing their positions, and 26 closing their positions.
31% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 26
4% more funds holding
Funds holding: 221 → 229 (+8)
5% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 84
1.71% less ownership
Funds ownership: 96.36% → 94.66% (-1.7%)
13% less capital inflows, than outflows
Capital inflows: $75.4M | Capital outflows: $86.4M
54% less call options, than puts
Call options by funds: $587K | Put options by funds: $1.26M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$25.4M |
| 2 |
Oberweis Asset Management
Lisle,
Illinois
|
+$8.52M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.7M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
+$3.29M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CastleKnight Management
New York
|
-$6.45M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$4.16M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.06M |
| 4 |
Advisors Preferred
Rockville,
Maryland
|
-$3.95M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.84M |
PAHC Hedge Fund Activity: Q4 2025 in Review
229 of the 8,303 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2025, worth a combined $723M — down 8.9% from $794M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new PAHC positions and 26 closed out — a net gain of 8 holders — while 80 added to existing stakes and 84 trimmed.
The largest buyer was Millennium Management, adding an estimated $25.4M. The largest seller was CastleKnight Management, cutting an estimated $6.45M.
- 229 institutional investors held Phibro Animal Health (PAHC) as of Q4 2025, up from 221 in Q3 2025.
- Funds reported $723M of Phibro Animal Health stock for Q4 2025, down 8.9% quarter-over-quarter.
- 34 funds opened new Phibro Animal Health positions in Q4 2025 and 26 closed out, a net change of +8 holders.
- The largest Phibro Animal Health buyer in Q4 2025 was Millennium Management, an estimated $25.4M added.
- The largest Phibro Animal Health seller in Q4 2025 was CastleKnight Management, an estimated $6.45M sold.
Based on aggregated 13F filings for Q4 2025.